Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of 'MRTX-500' and 'Carcinoma, Non-Small-Cell Lung', while significant details about the study's methodology and investigational agents have been removed.SummaryDifference12%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.